Human Growth Hormone Market 2022: Size, Top Companies, Latest Insights and Forecast to 2027

According to IMARC Group’s latest report, titled "Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027",  offers a comprehensive analysis of the industry, which comprises insights on the human growth hormone market trends.

The global human growth hormone market size reached US$ 4.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2027, exhibiting a CAGR of 8.47% during 2022-2027.  Human growth hormone (HGH) refers to a peptide hormone produced by the pituitary gland to promote growth and development in children and adolescents. The hormone mainly regulates the growth, regeneration, repair, reproduction, and metabolism of the cells, thereby contributing to the overall body development. HGH also helps in regulating body fluids, fat metabolism, and bone and muscle growth. The deficiency of HGH can increase the risk of growth-related ailments and fat accumulation in children and adults, whereas the higher HGH levels may cause gigantism, muscle-wasting disease, acromegaly, and short bowel syndrome.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/human-growth-hormone-market/requestsample

Human Growth Hormone Market Trends:

The increasing consumer health consciousness, along with the growing awareness towards several preventive measures against endocrine disorders, is also propelling the global market for HGH drugs. Various medical ailments, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), that are caused by the deficiency of HGH in the body, have also augmented the demand for HGH drugs. Furthermore, the growing utilization of HGH as performance enhancer by weightlifters, along with extensive R&D activities pertaining to recombinant human growth hormone (rHGH), are further expected to drive the market growth.

Human Growth Hormone Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the human growth hormone market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Eli Lilly and Company
• EMD Serono Inc.
• F. Hoffmann-La Roche AG
• Ferring B.V.
• Genentech Inc.
• Ipsen
• Merck KGaA
• Novartis AG
• Novo Nordisk
• Pfizer Inc.
• Sandoz, etc.

Key Market Segmentation:

The report has segmented the global human growth hormone market on the basis of application, distribution channel, route of administration and region.

Breakup by Application:

• Growth Hormone (GH) Deficiency
• Adult GH Deficiency
• Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature (ISS)
• Prader-Willi Syndrome (PWS)
• Small for Gestational Age
• Others

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Breakup by Route of Administration:

• Intravenous
• Intramuscular
• Subcutaneous
• Oral

Breakup by Region:

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
• Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/human-growth-hormone-market

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

30 N Gould St, Ste R

Sheridan, WY 82801, USA

Website: https://www.imarcgroup.com/

Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Article source: https://article-realm.com/article/Sports-Recreation/34459-Human-Growth-Hormone-Market-2022-Size-Top-Companies-Latest-Insights-and-Forecast-to-2027.html